OTC Markets OTCQB - Delayed Quote USD
Panbela Therapeutics, Inc. (PBLA)
At close: 3:07 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
29,036.0000
25,647.0000
34,093.0000
10,010.0000
5,754.0000
Operating Income
-29,036.0000
-25,647.0000
-34,093.0000
-10,010.0000
-5,754.0000
Net Non Operating Interest Income Expense
-627.0000
-194.0000
-274.0000
-11.0000
-17.0000
Other Income Expense
1,592.0000
392.0000
-682.0000
-602.0000
708.0000
Pretax Income
-28,071.0000
-25,449.0000
-35,049.0000
-10,623.0000
-5,063.0000
Tax Provision
-158.0000
-186.0000
-116.0000
-488.0000
-295.0000
Net Income Common Stockholders
-27,913.0000
-25,263.0000
-34,933.0000
-10,135.0000
-4,768.0000
Diluted NI Available to Com Stockholders
-27,913.0000
-25,263.0000
-34,933.0000
-10,135.0000
-4,768.0000
Basic EPS
-34.51
-316.52
-19.97k
-18.10k
-11.86k
Diluted EPS
-34.51
-316.52
-19.97k
-18.10k
-11.86k
Basic Average Shares
3,277.0860
108.6910
1.7490
0.5600
0.4020
Diluted Average Shares
3,277.0860
108.6910
1.7490
0.5600
0.4020
Total Operating Income as Reported
-29,036.0000
-25,647.0000
-34,093.0000
-10,010.0000
-5,754.0000
Total Expenses
29,036.0000
25,647.0000
34,093.0000
10,010.0000
5,754.0000
Net Income from Continuing & Discontinued Operation
-27,913.0000
-25,263.0000
-34,933.0000
-10,135.0000
-4,768.0000
Normalized Income
-28,683.6378
-25,660.0400
-34,933.0000
-10,135.0000
-4,865.4380
Interest Income
9.0000
123.0000
14.0000
1.0000
--
Interest Expense
636.0000
317.0000
288.0000
12.0000
17.0000
Net Interest Income
-627.0000
-194.0000
-274.0000
-11.0000
-17.0000
EBIT
-27,435.0000
-25,132.0000
-34,761.0000
-10,611.0000
-5,046.0000
EBITDA
-27,435.0000
-25,132.0000
-34,761.0000
-10,611.0000
-5,046.0000
Net Income from Continuing Operation Net Minority Interest
-27,913.0000
-25,263.0000
-34,933.0000
-10,135.0000
-4,768.0000
Total Unusual Items Excluding Goodwill
775.0000
400.0000
--
--
103.0000
Total Unusual Items
775.0000
400.0000
--
--
103.0000
Normalized EBITDA
-28,210.0000
-25,532.0000
-34,761.0000
-10,611.0000
-5,149.0000
Tax Rate for Calcs
0.0000
0.0000
0.0000
0.0000
0.0001
Tax Effect of Unusual Items
4.3622
2.9600
--
--
5.5620
12/31/2020 - 1/3/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ENTO Entero Therapeutics, Inc.
0.4533
+9.23%
EVLO Evelo Biosciences, Inc.
0.0005
0.00%
NEXI NexImmune, Inc.
0.3000
+36.24%
PCSA Processa Pharmaceuticals, Inc.
0.8601
-2.26%
EVFM Evofem Biosciences, Inc.
0.0100
+2.04%
DRMA Dermata Therapeutics, Inc.
1.1371
-3.64%
AVTE Aerovate Therapeutics, Inc.
2.6600
+1.92%
AJ8.MU Agenus Inc
2.6400
+3.13%
UQ1.F uniQure N.V.
5.38
+3.14%
1U5.F Wave Life Sciences Ltd.
13.60
+1.49%